期刊文献+

血清C反应蛋白变化在社区获得性肺炎病情评估中的价值 被引量:8

Significance of detecting serum C-reactive protein in evaluating community-acquired pneumonia
原文传递
导出
摘要 目的探讨血清C反应蛋白(CRP)水平的变化在社区获得性肺炎(CAP)病情及预后评估中的价值。方法收集CAP患者356例,初诊时和治疗后第4天检测血清CRP水平,观察符合重症肺炎病例数和随访30 d病死率。采用多元回归分析的方法评估预测价值。结果纳入研究范围的356例患者中,符合重症肺炎34例,30 d病死率是7.0%。较低水平的CRP对30 d病死率显示较高的阴性预测值,CRP<100 mg/L是减少重症肺炎(OR 0.22)(P<0.01)和30 d病死率(OR 0.17)(P<0.05)风险的独立危险因素。263例患者第4天重复测量了血清CRP水平。第4天的CRP水平下降少于50%或升高增加重症肺炎(OR 4.9)(P<0.01)和30 d病死率(OR 20.6)(P<0.01)风险。结论 CRP是评估CAP严重程度的独立预测因素。CRP<100 mg/L提示重症肺炎风险和30 d病死率降低。第4天CRP水平下降不足50%或上升提示重症肺炎风险和30 d病死率增加。 Objective To evaluate the significance of detecting serum C-reactive protein(CRP) in evaluating community-acquired pneumonia.Methods Serum levels of CRP were measured in 356 patients both on admission and on the 4th day.The case unmber of severe pneumonia and 30-day mortality were recorded.The value of predictive tests was assessed using multivariate logistic regression.Results The case unmber of severe pneumonia was 34 and 30-day mortality was 7.0%.Low CRP levels showed a high negative predictive value for excluding 30-day mortality.The CRP level of 100 mg/L was independently associated with the lower case number of severe pneumonia(OR=0.22)(P0.01) and 30-day mortality(OR=0.17)(P0.05).The CRP level that failled to falling by 50% or more on the 4th day was independently associated with increased severe pneumonia(OR=4.9)(P0.01) and 30-day mortality (OR=20.6)(P0.01).Conclusion Serum level of C-reactive protein is an independent marker in assessment of the severity of community-acquired pneumonia.Serum level of CRP100 mg/ L on admission predicts a low risk for severe pneumonia and 30-day mortality.The CRP level that failled to falling by 50% or more on the 4th day indicates an increase of the risk for severe pneumonia and 30-day mortality.
作者 施斌 施毅
出处 《江苏医药》 CAS CSCD 北大核心 2011年第7期781-784,共4页 Jiangsu Medical Journal
基金 江苏省卫生厅科技项目(H201060)
关键词 C反应蛋白 社区获得性肺炎 C-reactive protein Community-acquired pneumonia
  • 相关文献

参考文献5

  • 1Niederman MS, McCombs JI, Unger AN, et al. The cost of treating community-acquired pneumonia[J]. Clin Ther, 1998, 20(4):820-837.
  • 2Michael S. Making sense of scoring systems in community acquired pneumonia[J]. Respirology,2009,14(3):327-335.
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 4Castell JV, Gomez-Lechon MJ, David M, et al. Acute phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6 [J]. Hepatology, 2000,12 (5) : 1179-1186.
  • 5Adinirall J,Bolibar I, Toran P, et al. Contribution of c-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia[J]. Chest, 2004,125 (4) : 1192-1195.

二级参考文献24

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:784
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.

共引文献3031

同被引文献72

引证文献8

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部